LOS ANGELES, July 31, 2023 (GLOBE NEWSWIRE) -- Solve GNE, a Los Angeles based non-profit organization, has raised over $2.5 million and negotiated sponsored research agreements with multiple leading ...
Soroya Nazarian learned about hereditary inclusion body myopathy (HIBM), an uncommon muscular disorder that affects the Persian Jewish community, while in Israel on a Hadassah mission about five years ...
NOVATO, Calif., Oct. 5, 2011 /PRNewswire/ -- Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that ...
Based on clues provided by a study with transgenic mice, a research group at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has developed a ...
NOVATO, Calif., Aug. 15, 2011 /PRNewswire/ -- Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced the ...
On a winter evening in 1997, two dozen members of Los Angeles' Persian-Jewish community gathered in a spacious house in Woodland Hills. The home belonged to Houshang and Shokouh Darvish, Persian Jews ...
The alternative text for this image may have been generated using AI. ManNAc was tolerated well by the treated mice, as kidney and liver function tests were normal (Supplementary Table 1 online). In ...
LOS ANGELES, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Solve GNE announced today that it has entered into a sponsored research agreement with Genosera to provide funding for a novel Adeno-Associated Virus ...
As young adults, brothers Babak and Daniel Darvish, born less than two years apart, were avid athletes, music lovers and medical students who planned to become surgeons. But about five years ago, they ...
Rehovot, Israel--Researchers from the Weizmann Institute of Science and from Hadassah University Hospital have identified the gene that in its mutated form causes a degenerative muscle disease known ...
Based on clues provided by a study with transgenic mice, scientists have developed a strategy that will be tested as the first treatment for people with hereditary inclusion body myopathy (HIBM), a ...